A quantitative evaluation of the permeability of the blood brain barrier of portacaval shunted bats

被引:13
作者
Alexander, B
Li, X
Benjamin, IS
Segal, MB
Sherwood, R
Preston, JE
机构
[1] Kings Coll London, Sch Med & Dent, Dept Clin Biochem, London SE5 9PJ, England
[2] St Thomas Hosp, GKT Sch Med & Dent, Acad Dept Surg, Liver Sci Unit, London SE1 7RH, England
[3] St Thomas Hosp, GKT Sch Med & Dent, Sherrington Sch Physiol, London SE1 7RH, England
[4] Kings Coll London, Inst Gerontol, London WC2R 2LS, England
基金
英国惠康基金;
关键词
blood-brain barrier; portal-systemic encephalopathy; portacaval anastomosis; amino acids;
D O I
10.1007/BF02679976
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The integrity of the blood-brain barrier (BBB) was measured in male Sprague Dawley rats subjected to 16 weeks of portacaval shunting (PCS), the optimal time required for the cerebral changes to develop, by using an in situ brain perfusion technique. The penetration of a vascular space marker C-14 mannitol, and labelled amino acids H-3-phenylalanine or H-3-glutamate were measured in brain and cerebrospinal fluid (CSF) using an in situ brain perfusion technique, over 2 or 20 minutes. The patency of the surgical shunt was confirmed by measurement of significantly increased plasma ammonia (131.5 +/- 14.8 mu mol.l(-1)) and AST (159.5 +/- 19.9 IU.I-1) concentrations compared to controls 39.9 +/- 3.7*, and 82.5 +/- 6.6* respectively. Brain and CSF C-14-mannitol space (ml.100g(-1)), was not increased by PCS where brain space was 1.31 +/- 0.27 mL. 100g(-1) compared to control 1.19 +/- 0.49 mL. 100g(-1), and CSF was 0.14 +/- 0.06 mL. 100g(-1) compared to control 0.15 +/- 0.05 (PCS n=10, control n=8). The uptake for H-3-glutamate, which is required for cerebral ammonia detoxification, was also unchanged in both brain and CSF. However, brain uptake of H-3-phenylalanine was significantly reduced from 871 +/- 80 muL.min(-1).g(-1) to 356 +/- 154* mul.min(-1).g(-1) (n=4), although there was no change in CSF uptake. These data suggest that there is no generalized breakdown of the blood-brain or blood-CSF barriers during PCS as assessed by mannitol penetration. The reduction in phenylalanine uptake into the brain may help stabilize high cerebral aromatic amino acid levels. *P<0.05, Two-tailed, Student's unpaired t-test.
引用
收藏
页码:93 / 103
页数:11
相关论文
共 37 条
[1]   An investigation of the relationship between the liver and brain using an isolated perfused rat brain preparation [J].
Alexander, B ;
Aslam, M ;
Benjamin, IS .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 1999, 42 (01) :31-37
[2]   Differentiation between the effects of unprocessed portal blood and reduced liver function on brain indole amine metabolism in the portacaval shunted rat [J].
Alexander, B ;
Aslam, M ;
Nobin, A ;
Benjamin, IS .
METABOLIC BRAIN DISEASE, 1998, 13 (02) :137-146
[3]   The dependence of hepatic function upon sufficient oxygen supply during prolonged isolated rat liver perfusion [J].
Alexander, B ;
Aslam, M ;
Benjamin, IS .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 1998, 39 (04) :185-192
[4]  
ALEXANDER B, 1992, J PHYSL, V425, pP647
[5]  
ALEXANDER B, 1991, BRIT J PHARMACOL, V104, pP308
[6]   The entry of acidic amino acids into brain and CSF during development, using in situ perfusion in the rat [J].
AlSarraf, H ;
Preston, JE ;
Segal, MB .
DEVELOPMENTAL BRAIN RESEARCH, 1995, 90 (1-2) :151-158
[7]   Changes in the kinetics of the acidic amino acid brain and CSF uptake during development in the rat [J].
AlSarraf, H ;
Preston, JE ;
Segal, MB .
DEVELOPMENTAL BRAIN RESEARCH, 1997, 102 (01) :127-134
[8]   PORTACAVAL TRANSPOSITION IN THE RAT - DEFINITION OF A VALUABLE MODEL FOR HEPATIC RESEARCH [J].
BENJAMIN, IS ;
RYAN, CJ ;
ENGELBRECHT, GHC ;
CAMPBELL, JAH ;
VANHOORNHICKMAN, R ;
BLUMGART, LH .
HEPATOLOGY, 1984, 4 (04) :704-708
[9]   Elevated brain 5-hydroxytryptophol levels in experimental portal-systemic encephalopathy [J].
Bergqvist, PBF ;
Some, M ;
Apelqvist, G ;
Helander, A ;
Bengtsson, F .
PHARMACOLOGY & TOXICOLOGY, 1997, 80 (04) :187-190
[10]   Acute effects of L-tryptophan on brain extracellular 5-HT and 5-HIAA levels in chronic experimental portal-systemic encephalopathy [J].
Bergqvist, PBF ;
Hjorth, S ;
Apelqvist, G ;
Bengtsson, F .
METABOLIC BRAIN DISEASE, 1996, 11 (03) :269-278